WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
WX was delisted on the 10th of December, 2015.
154 hedge funds and large institutions have $1.91B invested in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in 2014 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 57 increasing their positions, 66 reducing their positions, and 26 closing their positions.
122% more call options, than puts
Call options by funds: $3.56M | Put options by funds: $1.6M
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
6% less funds holding
Funds holding: 164 → 154 (-10)
12% less capital invested
Capital invested by funds: $2.17B → $1.91B (-$265M)
14% less repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 66
38% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 26
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$82.7M |
| 2 |
Ninety One (UK)
London,
United Kingdom
|
+$40M |
| 3 |
CCM
Consonance Capital Management
New York
|
+$24.4M |
| 4 |
RFC
Russell Frank Company
Seattle,
Washington
|
+$22M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
+$18.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CI Investments Inc
Toronto,
Ontario, Canada
|
-$54.7M |
| 2 |
Bank of New York Mellon
New York
|
-$35.7M |
| 3 |
Principal Financial Group
Des Moines,
Iowa
|
-$34.8M |
| 4 |
William Blair & Company
Chicago,
Illinois
|
-$26.7M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$25.5M |
WX Hedge Fund Activity: Q2 2014 in Review
154 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) for Q2 2014, worth a combined $1.91B — down 12% from $2.17B a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of WX and 16 opened new positions — a net loss of 10 holders — while 66 trimmed existing stakes and 57 added.
The largest buyer was Wellington Management Group, adding an estimated $82.7M. The largest seller was CI Investments Inc, exiting entirely with an estimated $54.7M sold.
- 154 institutional investors held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) as of Q2 2014, down from 164 in Q1 2014.
- Funds reported $1.91B of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS stock for Q2 2014, down 12% quarter-over-quarter.
- 16 funds opened new WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS positions in Q2 2014 and 26 closed out, a net change of -10 holders.
- The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS buyer in Q2 2014 was Wellington Management Group, an estimated $82.7M added.
- The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS seller in Q2 2014 was CI Investments Inc, an estimated $54.7M sold.
Based on aggregated 13F filings for Q2 2014.